Support in Product Development and Outlicensing ASPIRAS was supporting Galantos Pharma GmbH in the preclinical phase of development. Galantos Pharma develops better tolerated and targeted products against the spreading Alzheimer’s disease based on the natural substance Galantamin. ASPIRAS was planning project activities step by step according to the Notice to Applicants and also recommends contract organisations for performing experiments. -> Letter of Excellence
			Consulting in company start-up and business development ASPIRAS assisted Medovent GmbH, a young enterprise in the field of medical devices, from the stage of business plan preparation through to negotiations with investors and setting up the company. High-Tech-Gründerfonds and the federal state of Rhineland-Palatinate agreed to invest in the company, and business coaching by ASPIRAS is on-going. -> Letter of Excellence
			Support in Marketing and Sales At Orpegen ASPIRAS is supporting the activities in marketing and product sales via connecting the company with relevant potential customers in the pharmaceutical and biotech industry. We are scheduling meetings, attending the client’s presentations and are actively furthering the cooperations.
			Management and marketing of an innovation centre with the focus on innovative drug formulations At the Sinzig centre for innovation and entrepreneurship we are responsible for management and marketing. Part of the task is to establish the institute as a competence centre for research and development in the area of innovative drug formulations. -> Letter of Excellence
			Strategy development For the Fraunhofer-Verbund Life Sciences (FhG-VLS) ASPIRAS developed a proposal for a future-orientated strategy in the area of pharma-related research and development services. The concept proposed by ASPIRAS is based on the key competences within FhG-VLS and particularly takes into account trends in modern biomedical research. -> Letter of Excellence
			Evaluation of options for a new OTC product Johnson&Johnson/MSD Consumer Pharmaceuticals Europe asked ASPIRAS to evaluate the options for a new OTC-product. The Project included data research, the combination of decision criterions based on medical, pharmaceutical, technical and economical aspects as well as the development of registration scenarios. In the same way the situation of competitive products around Europe was analysed. Based on the gained data ASPIRAS could give a clear recommendation for the future activities.
			Support in Business Development We supported a bioinformatics company in business development via connecting the company with relevant potential customers in the pharmaceutical industry. We scheduled meetings, attended the client’s presentations and actively furthered the cooperations. -> Letter of Excellence
			Performing a Due Diligence For the Japanese Sumitomo we performed a due diligence on a German biotech firm active in the field of diagnostics prior to an investment.
			Support in Line Extension For the German Nycomed Pharma ASPIRAS analysed opportunities for line-extension into a new indication and a new specialist doctors‘ segment and put together a product portfolio in this area.